MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210
Press release content from Business Wire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Systemic Lupus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Business Wire. The AP news staff was not involved in its creation.
/PRNewswire/ -- DelveInsight's Systemic Lupus Erythematosus Market Insights report proffers a detailed comprehension of the Systemic Lupus Erythematosus market...
DGAP-News: MorphoSys AG / Key word(s): AgreementMorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210 14.06.2022 / 22:01 The issuer is solely responsible for the content of this announcement.Media ReleasePlanegg/Munich, Germany, South San Francisco, United States, June...
DGAP-News: MorphoSys AG / Key word(s): Agreement MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felza...
Early-career scientists receive funding to pursue arthritis and related autoimmune disease researchIRVINE, Calif.--(BUSINESS WIRE)--The Arthritis National Research Foundation (ANRF) today announced the 19 early-career scientists who will receive grant funding and make up the 2022-23 cohort. The eight first-year gran...